Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Pennsylvania guidePennsylvania Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Pennsylvania
  4. ›Healthcare and Medical Services
  5. ›Research to Cure & Prevent T1 Juvenile Diabetes

Pennsylvania Department of Health·Pennsylvania

Research to Cure & Prevent T1 Juvenile Diabetes

Closes 11/24/2025$500k – $2.4MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Health is seeking research proposals to cure and prevent T1 (Juvenile) Diabetes. The proposed research should focus on discovering new knowledge that can be applied to improve health status. The research project may involve human subjects and should address health disparities. The proposal should include a detailed research plan, a management and staffing plan, and a budget narrative. The Department will provide funding for a period of up to 48 months, with a maximum of $500,000 per year. The proposal should be submitted electronically and must be received by the Department no later than 1:30 PM on November 24, 2025. • The research proposal should include a specific aim related to minority training. • The proposal should describe the methods for achieving the aims and subaims. • The proposal should include a detailed budget narrative. • The proposal should include a management and staffing plan. • The proposal should include a research plan that describes the conceptual framework, research design, and limitations of the research design.

Attached files

Contact

Sylvia Golas(Procurement Contact)

[email protected]

(717) 547-3103

Key dates

Opened
9/24/2025
Closes
11/24/2025
Duration
48 months

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA67-205

Budget estimate

$500,000 – $2,400,000

Based on the information provided, the estimated budget for this opportunity could range from $500,000 to $2,400,000 over the 48-month period, assuming a maximum of $500,000 per year. The actual budget may vary depending on the specific requirements of the research project and the Department's funding decisions.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 71%

The Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes

Closes 10/12/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

70% match

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

Closes 3/10/2027Opened 9/18/2025

U.S. National Institutes of Health·United States of America

69% match

Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)

Closes 3/9/2027Opened 8/4/2026

U.S. National Institutes of Health·United States of America

67% match

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

Closes 11/9/2026Opened 1/29/2026

U.S. National Institutes of Health·United States of America

66% match

Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)

Closes 2/9/2027Opened 8/20/2026

U.S. National Institutes of Health·United States of America

66% match

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers

Closes 10/31/2026Opened 9/18/2025

U.S. Centers for Disease Control and Prevention - ERA·United States of America

66% match

Implementation Research on Multi-component Community-Clinical Linkage Approaches for Diabetes Prevention and Management

Closes 4/20/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

65% match

Diabetes Research Centers (P30 Clinical Trial Optional)

Closes 1/27/2027Opened 5/27/2025

U.S. Department Of Health And Human Services·Maryland

65% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024

U.S. National Institutes of Health·United States of America

65% match

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center

Closes 10/31/2026Opened 9/18/2025

U.S. Centers for Disease Control and Prevention - ERA·United States of America

63% match

CDC National Centers of Excellence in Youth Violence Prevention (YVPCs): Rigorous Evaluation of Prevention Approaches to Prevent and Reduce Youth Violence

Closes 1/1/2027Opened 7/2/2026

U.S. National Institutes of Health·United States of America

63% match

Childhood Asthma in Urban Settings Clinical Research Network

Closes 5/27/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

63% match

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

Closes 11/16/2027Opened 12/2/2024

U.S. National Institutes of Health·United States of America

63% match

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Closes 11/9/2026Opened 2/12/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

62% match

New Investigator Grants to Conduct Research to Prevent Interpersonal Violence and Suicide Among Children and Adolescents (K01)

Closes 1/1/2027Opened 7/2/2026

U.S. National Institutes of Health·United States of America

62% match

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Closes 8/21/2028Opened 5/13/2025

U.S. National Institutes of Health·United States of America

62% match

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/25/2021

U.S. National Institutes of Health·United States of America

62% match

Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 12/3/2024

U.S. National Institutes of Health·United States of America

62% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

62% match

Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)

Closes 11/17/2026Opened 9/18/2025

U.S. National Institutes of Health·United States of America

62% match

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

Closes 2/3/2027Opened 4/1/2024

U.S. National Institutes of Health·United States of America

61% match

Immune Tolerance Network (UM1 Clinical Trial Required)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

61% match

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

Closes 2/3/2027Opened 4/2/2024

U.S. National Institutes of Health·United States of America

61% match

Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)

Closes 9/24/2027Opened 10/6/2026

U.S. National Institutes of Health·United States of America

61% match

The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)

Closes 10/31/2026Opened 9/18/2025